The classifications of tumors by the World Health Organization (WHO) are continuously updated to incorporate the latest scientific advancements and findings from numerous studies conducted by scientific research centers and universities around the world. In the era of globalization and easy access to scientific information, we can anticipate more frequent revisions of these classifications. In 2018, the WHO published an updated histopathological classification of skin tumors. The previous edition had been in use since 2006, necessitating an update to accurately and precisely describe the malignant processes involved. Descriptions of squamous cell carcinoma of the skin (cSCC) in the new classification are systematized similarly to the previous one, based on epidemiology, etiology, pathogenesis, histopathology, clinical features, anatomic location, staging, predictive, and prognostic factors. It sequentially covers premalignant keratoses, in situ forms, and invasive forms of squamous cell carcinoma. Adjustments have been made, certain histological variants have been added or removed, and keratoacanthomas, previously considered conditionally malignant, have now been categorically classified as squamous cell carcinomas in the current classification.
Aboul-Fettouh N, Nijhawan RI. Aggressive squamous cell carcinoma in a patient on the Janus kinase inhibitor ruxolitinib. JAAD Case Rep. 2018 Apr 30;4(5):455-457. doi: 10.1016/j.jdcr.2018.01.001. PMID: 29984281; PMCID: PMC6031591.
Ackerman AB, Guo Y, Vitale P (1992). Clues to Diagnosis in Dermatopathology II. ASCP Press: Chicago
Ackerman LV (1948) Verrucous carcinoma of the oral cavity. Surgery. 23(4):670-8. PMID: 18907508
Aird I, Johnson HD, Lennox B, Stansfeld AG (1954). Epithelioma cunuculatum: a variety of squamous cell carcinoma peculiar to the foot. Br J Surg. 42(173):245-50. PMID: 13219306
Alain G, Tousignant J, Rozenfarb E (1993). Chronic arsenic toxicity. Int J Dermatol 32: 899-901
Aleisa AI, Plante JG, Hisa L-LB. "A case of aggressive squamous cell carcinoma with lymphovascular invasion during treatment with the Janus kinase inhibitor tofacitinib." JAAD Case Reports 6.8 (2020): 727-730.
Alter BP, Giri N, Savage SA, Rosenberg PS. (2009). Cancer in dyskeratosis congenita. Blood, The Journal of the American Society of Hematology, 113(26), 6549-6557.
Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Rosenberg PS. (2010). Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. British journal of haematology, 150(2), 179-188.
Al-Arashi MY, Byers HR (2007). Cutaneous clear cell squamous cell carcinoma in situ: clinical, histological and immunohistochemical characterization. J Cutan Pathol. 34(3):226-33. PMID: 17302606
Andersson EM, Paoli J, Wastensson G. Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden, Cancer Epidemiology, Volume 35, Issue 6, 2011, Pages e69-e74, ISSN 1877-7821, https://doi.org/10.1016/j.canep.2011.05.006.
Anforth R, Fernandez-Peñas P, Long GV. Cutaneous toxicities of RAF inhibitors. Lancet Oncol. 2013 Jan;14(1):e11-8. doi: 10.1016/S1470-2045(12)70413-8. PMID: 23276366.
Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. (2000). The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. Journal of virology, 74(24), 11636-11641.
Ascierto PA, Minor D, Ribas A, Lebbe C, O’Hagan A, Arya N et al. (2013). Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma. J Clin Oncol, 31(26), 3205-3211.
Benavides F, Oberyszyn TM, VanBuskirk AM, Reeve VE, Kusewitt DF. The hairless mouse in skin research. J Dermatol Sci. 2009 Jan;53(1):10-8. doi: 10.1016/j.jdermsci.2008.08.012. Epub 2008 Oct 19. PMID: 18938063; PMCID: PMC2646590.
Benjamin CL, Ananthaswamy HN. (2007). p53 and the pathogenesis of skin cancer. Toxicology and applied pharmacology, 224(3), 241-248.
Bice TC, Tran V, Merkley MA, Newlands SD, van der Slot PG, Wu S et al. (2015) Disease-specific survival with spindle cell carcinoma of the head and neck. Otolaryngol. Head Neck Surg. 153(6):973-80. PMID: 26203085
Bhawan J (1988). Histology of epidermal dysplasia. J Cutan Aging Cosm Dermatol 1: 95-103
Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL et al. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol. 2015 Aug;54(8):e287-93. doi: 10.1111/ijd.12564. Epub 2015 Mar 13. PMID: 25772131.;
Brewster DH, Bhatti LA, Inglis JH, Nairn ER, Doherty VR. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol. 2007 Jun;156(6):1295-300. doi: 10.1111/j.1365-2133.2007.07892.x. PMID: 17535229.
Brimer N, Lyons C, Wallberg AE, Vande Pol SB. (2012). Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene, 31(43), 4639-4646.
Burkhardt A. (1986). Verrucous carcinoma and carcinoma cuniculatum-forms of squamous cell carcinoma? Hautarzt. 37(7):373-83[German] PMID: 3744823
Caglar H, Tamer S, Hreshchyshyn MM (1982). Vulvar intraepithelial neoplasia. Obstet Gynecol 60: 346-349
Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarre M et al. (2003). The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. Journal of virology, 77(3), 2195-2206
Chen P, Chen F, Zhou B. (2019). Systematic review and meta‐analysis of prevalence of dermatological toxicities associated with vemurafenib treatment in patients with melanoma. Clinical and experimental dermatology, 44(3), 243-251.
Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005 Feb 24;352(8):804-15. doi: 10.1056/NEJMra041720. PMID: 15728813.
Chu MB, Slutsky JB, Dhandha MM, Beal BT, Armbreht ES, Walker RJ et al. (2014) Evaluation of the definitions of “high-risk” cutaneous squamous cell carcinoma using the American Joint Committee on Cancer staging criteria and National Comprehensive Cancer Network guidelines. J Skin Cancer. 2014:154340. PMID: 25309755
Chung HJ, Wolpowitz D, Scot G, Gilmore E, Bhavan J (2016). Squamous cell carcinoma with osteoklast-like giant cells: a morphologically heterolougos group including carcinosarcoma and squamous cell carcinoma with stromal changes. J Cutan Pathol. 43(2): 148-57. PMID: 26272477
Cockerell CJ (2000). Histopathology of incipient intraepidermal squamous cell carcinoma (“actinic keratosis”). J Am. Acad Dermatol 42: 11-17.
Conforti C, Paolini F, Venuti A, Dianzani C, Zalaudek I. (2019). The detection rate of human papillomavirus in well-differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?. British Journal of Dermatology, 181(6), 1309-1311.
Corbalán-Vélez R, Ruiz-Macia JA, Brufau C, López-Lozano JM, Martínez-Barba E, Carapeto FJ. Las células claras en el carcinoma espinocelular cutáneo [Clear cells in cutaneous squamous cell carcinoma]. Actas Dermosifiliogr. 2009 May;100(4):307-16. Spanish. PMID: 19463234.
Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS et al. HPV Variant Study Group. (2012). Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. Journal of virology, 86(12), 6855-6861
Costache M, Desa LT, Mitrache LE, Patraşcu OM, Dimitru A, Costache D et al. (2014). Cutaneous verrucous carcinoma – report of three cases with review of literature. Rom J Morphol Embryol. 55(2):383-8. PMID: 24969990
Cramer SF, Heggeness LM (1989). Signet-ring squamous cell carcinoma. Am J Clin Pathol. 91(4):488-91. PMID: 2467552
Dalton SR, LeBoit PE (2008). Squamous cell carcinoma with clear cells: how often is there evidence of tricholemmal differentiation? Am J Dermatopathol. 30(4):333-9. PMID: 18645304
Das KK, Chakaraborty A, Rahman A, Khandkar S. (2015). Incidences of malignancy in chronic burn scar ulcers: experience from Bangladesh. Burns, 41(6), 1315-1321.
de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, Green AC et al. (2009). Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. Journal of general virology, 90(7), 1611-1621.
Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002 Apr;146 Suppl 61:1-6. doi: 10.1046/j.1365-2133.146.s61.2.x. PMID: 11966724.
El Demellawy D, Onuma K, Alowami S (2011). Signet ring squamous cell carcinoma-the forgotten variant: case report and review of the literature. J Cutam Pathol. 38(3):306-8. PMID: 19751229
Elder DE, Massi D, Scolyer RA, Willemze R, editors (2018) WHO classification of skin tumors. 4th ed. Lyon: IARC
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988 Jun;124(6):869-71. doi: 10.1001/archderm.124.6.869. PMID: 3377516.
Fu GM, McCalmont T, Yu SS (2009). Adenosquamous carcinoma of the skin: a case series. Arch Dermatol. 145(10):1152-8. PMID: 19841403
Garrett GL, Lowenstein SE, Singer JP, He SY, Arron ST. Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013. J Am Acad Dermatol. 2016 Jul;75(1):106-12. doi: 10.1016/j.jaad.2016.02.1155. Epub 2016 Apr 8. PMID: 27067869.
Greten FR, Grivennikov SI. (2019). Inflammation and cancer: triggers, mechanisms, and consequences. Immunity, 51(1), 27-41.
Grivennikov SI, Greten FR, Karin M. (2010). Immunity, inflammation, and cancer. Cell, 140(6), 883-899.
Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med. 2015 Feb;48(2):183-187. doi: 10.1016/j.amepre.2014.08.036. Epub 2014 Nov 10. PMID: 25442229; PMCID: PMC4603424.
Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, Gessner A et al. Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood. 2003 Jun 1;101(11):4457-63. doi: 10.1182/blood-2002-11-3370. Epub 2003 Jan 16. PMID: 12531798.
Harrison CN, Vannucchi AM, Kiladjian JJ, Al-Ali HK, Gisslinger H, Knoops L et al. (2016). Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia, 30(8), 1701-1707.
Harwood CA, Mesher D, McGregor JM, Mitchell L, Leedham-Green M, Raftery M, Cerio R, Leigh IM, Sasieni P, Proby CM. A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant. 2013 Jan;13(1):119-29. doi: 10.1111/j.1600-6143.2012.04292.x. Epub 2012 Oct 16. PMID: 23072567.
Howley PM, Pfister HJ. Beta genus papillomaviruses and skin cancer. Virology. 2015 May;479-480:290-6. doi: 10.1016/j.virol.2015.02.004. Epub 2015 Feb 24. PMID: 25724416; PMCID: PMC4424140.
Indinnimeo M, Impagnatiello A, D’Ettorre G, Bernardi G, Moschella CM, Gozzo P et al.(2013) Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases. World J Surg Oncol. 11:231. PMID: 24040860
Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):177-86. doi: 10.1016/s0190-9622(99)70185-4. PMID: 10025742.
Johnson WC, Helwig EB (1966). Adenoid squamous cell carcinoma (adenoacanthoma). A clinicopathologic study of 155 patients. Cancer 19: 1639-1650
Kadir AR. "Burn scar neoplasm." Annals of burns and fire disasters 20.4 (2007): 185.
Kang HC, Quigley DA, Kim IJ, Wakabayashi Y, Ferguson-Smith MA, D’Alessandro M et al. (2013). Multple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to know TGFBR1 mutations sugest a digenic or multilocus etiology. J Invest Dermatol. 133(7):1907-10. PMID: 23358096
Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003 Dec;149(6):1200-6. doi: 10.1111/j.1365-2133.2003.05554.x. PMID: 14674897.
Kerr-Valentic MA, Samimi K, Rohlen BH, Agarwal JP, Rockwell WB. Marjolin's ulcer: modern analysis of an ancient problem. Plast Reconstr Surg. 2009 Jan;123(1):184-191. doi: 10.1097/PRS.0b013e3181904d86. PMID: 19116552.
Kishikawa M, Koyama K, Iseki M, Kobuke T, Yonehara S, Soda M et al. (2005). Histologic characteristics of skin cancer in Hiroshima and Nagasaki: background incidence and radiation effects. International journal of cancer, 117(3), 363-369.
Koh SH, Oh SJ, Chun H, Kim SJ (2014). Pseudoangiosarcomatous squamous cell carcinoma developing on a burn scar: case report and review of literature. Bums. 40(7): e47-52. PMID: 24768344
Kuo T (1980). Clear cell carcinoma of the skin. A variant of the clear cell carcinoma that simulates sebaceous carcinoma. Am J Surg Pathol. 4(6): 573-83. PMID: 6163367
Kwiek B, Schwartz RA (2016). Keratoakanthoma (KA): an update and review. J Am Acad Dermatol. 74(6): 1220-33. PMID: 26853179
LeBoit PE, Burg G, Weedon D, Sarasain A. (Eds.): World Health Organization Classification of Tumors. Pathology and Genetics of Skin Tumors. IARC Press: Lyon 2006
Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer. 1996 Dec;74(11):1847-50. doi: 10.1038/bjc.1996.642. PMID: 8956805; PMCID: PMC2077229.
Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER et al. (2000). Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Archives of dermatology, 136(8), 1007-1011.)
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012 May;166(5):1069-80. doi: 10.1111/j.1365-2133.2012.10830.x. PMID: 22251204.
Longley BJ, Metcalfe DD (2000). A proposed classification of mastocytosis incorporating molecular genetics. Hematol Oncol Clin North Am 14: 697-701, viii.
Lund HZ (1965). How often does squamous cell carcinoma of the skin metastasize? Arch Dermatol 92: 635-637
March-Rodriguez Á, Bellosillo B, Álvarez-Larrán A, Besses C, Pujol RM, Toll A. Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib. Ann Dermatol. 2019 Apr;31(2):204-208. doi: 10.5021/ad.2019.31.2.204. Epub 2019 Feb 28. PMID: 33911570; PMCID: PMC7992689.
Marks R, Rennie G, Selwood TS (1988). Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1: 795-797
McKinley E, Valles R, Bang R, Bocklage T (1998). Signet-ring squamous cell carcinoma: a case report. J Cutan Pathol. 25(3):176-81. PMID: 9550318
Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J Am Acad Dermatol. 2005 Dec;53(6):1067-71. doi: 10.1016/j.jaad.2005.08.055. PMID: 16310071.
Mene A, Buckley CH (1985). Involvement of the vulval skin appendages by intraepithelial neoplasia. Br J Obstet Gynaecol 92: 634-638.
Moller R, Reymann F, Hou-Jensen K. (1979). Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol 115: 703-705
Nagore E, Sanchez Motilla JM, Perez-Vallez A, Martinez-Lahuerta C, Alegre V, Aliaga A (2000). Pseudovascular squamous cell carcinoma of the skin. Clin Exp Dermatol. 25(3): 2006-8. PMID: 10844496
Nakajima K, Kaneko T, Aizu T, Nakano H, Matsuzaki Y, Sawamura D (2013). Signet-ring cutaneous squamous cell carcinoma arising on the back of the finger. Case Rep Dermatol. 5(2): 215-8. PMID: 24019773
Nappi O, Pettinato G, Wick MR (1989). Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol 16: 114-121
Patel V, Squires SV, Liu DY, Fraga GR 2014. Cutaneous adenosquamous carcinoma: a rare neoplasm with biphasic differentiation. Cutis. 94(5):231-3. PMID: 25474451
Petter G, Haustein UF (2000). Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 26: 521-530
Pukkala E, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Tryggvadottir L et al. (2014). Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occupational and environmental medicine, 71(6), 398-404.)
Pyne JH, Myint E, Barr EM, Clark SP, David M, Na R. Acantholytic invasive squamous cell carcinoma: tumor diameter, invasion depth, grade of differentiation, surgical margins, perineural invasion, recurrence and death rate. J Cutan Pathol. 2017 Apr;44(4):320-327. doi: 10.1111/cup.12869. Epub 2017 Jan 16. PMID: 27991679.
Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018 Feb;78(2):237-247. doi: 10.1016/j.jaad.2017.08.059. PMID: 29332704.
Risitano AM, Marotta S, Calzone R, Grimaldi F, Zatterale A; RIAF Contributors. Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learned. Haematologica. 2016 Mar;101(3):319-27. doi: 10.3324/haematol.2015.133520. Epub 2015 Dec 3. PMID: 26635036; PMCID: PMC4815723.
Rossi R, Mori M, Lotti T (2007). Actinic keratosis Int J Dermatol 46(9):895-904. PMID: 17822489
Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho-Garnier H et al. The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996 Jun;73(11):1447-54. doi: 10.1038/bjc.1996.275. PMID: 8645596; PMCID: PMC2074492.
Royle JA, Baade PD, Joske D, Girschik J, Fritschi L. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer. 2011 Sep 27;105(7):1076-81. doi: 10.1038/bjc.2011.313. Epub 2011 Aug 16. PMID: 21847118; PMCID: PMC3185934.
Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature. 2012 Jul 26;487(7408):491-5. doi: 10.1038/nature11288. PMID: 22810586; PMCID: PMC3408847.
Sanches DF, Rodriguez IM, Piris A, Canete S, Lezcano C, Velazquez EF et al. (2016). Clear cell carcinoma of the penis: an HPV – related variant of squamous cell carcinoma: a report of three cases. Am J Surg Pathol. 40(7):917-22. PMID: 26848799
Santchez DF, Soares F, Alvarado-Cabrero I, Canete S, Fernandez-Nestosa MJ, Rodriguez IM et al. (2015) Pathological factors, behavior and histological prognostic risk groups in subtypes of penile squamous cell carcinoma (SCC). Semin. Diagn, Pathol. 32(3):222-31 PMID: 25677263
Schön MP, Heisterkamp T, Ahrens C, Megahed M, Ruzicka T, (2000). Presternal verrucous carcinoma. Hautarzt. 51(10):766-9.[German] PMID: 11153364
Schwarz RA (1995) Verrucous carcinoma of the skin and micosa. J Am Acad Dermatol. 32(1):1-21. PMID:7822496
Sinha RP, Häder DP. UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 1, 225–236 (2002). https://doi.org/10.1039/b201230h
Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006 Jan 2;184(1):6-10. doi: 10.5694/j.1326-5377.2006.tb00086.x. PMID: 16398622.
Stenehjem JS, Robsahm TE, Bråtveit M, Samuelsen SO, Kirkeleit J, Grimsrud TK. Ultraviolet radiation and skin cancer risk in offshore workers. Occup Med (Lond). 2017 Oct 1;67(7):569-573. doi: 10.1093/occmed/kqx110. PMID: 29048595.
Tan MJA, White EA, Sowa ME, Harper JW, Aster JC, Howley, PM. (2012). Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proceedings of the National Academy of Sciences, 109(23), E1473-E1480.
Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol. 2009 May;9(5):324-37. doi: 10.1038/nri2546. PMID: 19390566; PMCID: PMC2847476.
Uberoi A, Lambert PF (2017). Rodent papillomaviruses. Viruses, 9(12), 362.
Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG et al. (1999), Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer, 85: 1758-1764. https://doi.org/10.1002/(SICI)1097-0142(19990415)85:8<1758::AID-NCR16>3.0.CO;2-F
Viarisio D, Decker KM, Aengeneyndt B, Flechtenmacher C, Gissmann L, Tommasino M. (2013). Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis. Journal of General Virology, 94(4), 749-752.
Wallace NA, Robinson K, Howie HL, Galloway DA. (2012). HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS pathogens, 8(7), e1002807.
Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J et al. (2005). Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. Journal of Investigative Dermatology, 125(1), 93-97.
Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K et al. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature. 2010 May 20;465(7296):368-72. doi: 10.1038/nature08996. PMID: 20485437; PMCID: PMC3050632.
Xiang F, Song HP, Huang YS. Clinical features and treatment of 140 cases of Marjolin's ulcer at a major burn center in southwest China. Exp Ther Med. 2019 May;17(5):3403-3410. doi: 10.3892/etm.2019.7364. Epub 2019 Mar 7. PMID: 30988718; PMCID: PMC6447797.
Yarosh DB, Pena AV, Nay SL, Canning MT, Brown DA. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol. 2005 Nov;125(5):1020-5. doi: 10.1111/j.0022-202X.2005.23858.x. PMID: 16297204.
Yoshinaga S, Hauptmann M, Sigurdson AJ, Doody MM, Freedman DM, Alexander BH et al. Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists. Int J Cancer. 2005 Jul 10;115(5):828-34. doi: 10.1002/ijc.20939. PMID: 15704092.
Yu HS, Liao WT, Chai CY. (2006). Arsenic carcinogenesis in the skin. Journal of biomedical science, 13, 657-666.
Yu N, Long X, Lujan-Hernandez JR, Hassan KZ, Bai M, Wang Y et al. Marjolin's ulcer: a preventable malignancy arising from scars. World J Surg Oncol. 2013 Dec 17;11:313. doi: 10.1186/1477-7819-11-313. PMID: 24341890; PMCID: PMC3896958.
З. Валерианова 2014. Национална болница по онкология National Oncological Hospital
Български национален раков регистър Bulgarian National Cancer Registry
https://www.sbaloncology.bg/assets/files/rakov_registar/rakov_registyr_2017.pdf
